» Articles » PMID: 31255606

A Meta-analysis of Pregnancy-related Outcomes and Complications in Women with Polycystic Ovary Syndrome Undergoing IVF

Overview
Publisher Elsevier
Date 2019 Jul 1
PMID 31255606
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

This meta-analysis aimed to study whether pregnancy-related outcomes and complications differed between patients with polycystic ovary syndrome (PCOS) and those with other causes of infertility who had undergone IVF. A systematic search of PubMed, Embase, the Cochrane Library and Chinese databases was carried out to identify relevant studies published before July 2018. Outcomes were expressed as odds ratios (OR) and 95% confidence intervals (CI). Subgroup analyses and sensitivity analyses were also conducted. Twenty-nine studies were identified for inclusion. Women with PCOS had higher risks of miscarriage (OR 1.41, 95% CI 1.04-1.91), ovarian hyperstimulation syndrome (OR 4.96, 95% CI 3.73-6.60), gestational diabetes mellitus (OR 2.67, 95% CI 1.43-4.98), pregnancy-induced hypertension (OR 2.06, 95% CI 1.45-2.91), preterm birth (OR 1.60, 95% CI 1.25-2.04) and large-for-gestational-age babies (OR 2.10, 95% CI 1.01-4.37). Women with PCOS showed similar rates of clinical pregnancy, multiple pregnancy, ectopic pregnancy, small for gestational age and congenital malformations, and a higher live birth rate, compared with women without PCOS. This study provides an update on and comprehensive evidence to support the observation that despite the fact that PCOS patients achieve a better live birth rate, physicians should continue to consider them to be at high risk of adverse pregnancy-related outcomes.

Citing Articles

Enhancing understanding of endometrial function in patients with PCOS: clinical and immunological insights.

Guo Y, Yang J, Chen H, Zhou Y, Yang Y, Wang B J Ovarian Res. 2025; 18(1):52.

PMID: 40075432 PMC: 11900192. DOI: 10.1186/s13048-025-01638-x.


Impact of Polycystic Ovary Syndrome Hyperandrogenic Phenotypes A and Non-Hyperandrogenic D on Pregnancy Outcomes After in vitro Fertilization (IVF)/Intracytoplasmic Sperm Injection (ICSI).

Khamaiseh K, Bdeir R, Abukbeer M, Khamaiseh R, Nassar A, Al-Sawadha D Int J Womens Health. 2025; 17:561-569.

PMID: 40051655 PMC: 11884253. DOI: 10.2147/IJWH.S500692.


Polycystic ovary syndrome as a metabolic disease.

Helvaci N, Yildiz B Nat Rev Endocrinol. 2024; .

PMID: 39609634 DOI: 10.1038/s41574-024-01057-w.


Contribution of cervical incompetence to occurrence of second trimester abortion in patients with polycystic ovary syndrome during the frozen embryo transfer cycle.

Cheng T, Shi H, Bu Z, Yu Y, Song W, Haixia J Front Endocrinol (Lausanne). 2024; 15:1411618.

PMID: 39479270 PMC: 11521832. DOI: 10.3389/fendo.2024.1411618.


Association between Age and Miscarriage in an Assisted Reproductive Technology Population: A 10-Year Cohort Study.

Zhao D, Chen J, Li X, Li Z, Zhang J, Gao C Iran J Public Health. 2024; 53(9):2030-2039.

PMID: 39429668 PMC: 11490329. DOI: 10.18502/ijph.v53i9.16456.